Make Sure You Stick With Xeris Biopharma Holdings Inc (XERS). It’s Bull Time Again

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Xeris Biopharma Holdings Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Xeris Biopharma Holdings Inc is $771.24M. A total of 2.54 million shares were traded on the day, compared to an average of 3.15M shares.

In the most recent transaction, Fairley Ricki Louise bought 56,667 shares of XERS for 4.90 per share on May 09 ’25. In a previous transaction on Mar 20 ’25, Hecht Beth sold 40,000 shares at 5.43 per share. XERS shares that the insider owns now total 1,353,510.

Among the insiders who bought shares, Hecht Beth acquired of 40,000 shares on Mar 20 ’25 at a per-share price of $5.14. In another insider transaction, Schmid John P. bought 4,515 shares at $2.25 per share on Aug 12 ’24. Company shares held by the Director now total 25,200.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, XERS has a high of $6.07 and a low of $1.72.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. XERS’s latest balance sheet shows that the firm has $102.43M in Cash & Short Term Investments as of fiscal 2021. There were $88.07M in debt and $79.04M in liabilities at the time. Its Book Value Per Share was -$0.23, while its Total Shareholder’s Equity was $95.23M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XERS is Buy with a score of 4.67.

Most Popular

Related Posts